Tersera Therapeutics

ZOLADEX

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ZOLADEX – J9202

Manufacturer:

Tersera Therapeutics

Name:

ZOLADEX

HCPCS Code Descriptor:

Goserelin acetate implant, per 3.6 mg

Category:

J Code

HCPCS:

J9202

NDC(s):

70720-0950-36, 70720-0951-30

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

ZOLADEX is an Oncology drug manufactured by Tersera Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9202 is aligned to the drug ZOLADEX.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/91

HCPCS Effective Date:

1/1/97

HCPCS Short Description:

Goserelin acetate implant

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.zoladex.com/

ZOLADEX - J9202